Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research …

A Dima, MC Vonk, A Garaiman, BE Kersten… - European Journal of …, 2024 - Elsevier
Abstract Background The anti-Nucleolar Organizer Region 90 antibodies (NOR90) are rare
antinuclear antibodies (ANA) reported in systemic sclerosis (SSc). Especially due to low …
被引用次数：1 相关文章

Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research …

A Dima, MC Vonk, A Garaiman, BE Kersten… - European Journal of …, 2024 - europepmc.org
Background The anti-Nucleolar Organizer Region 90 antibodies (NOR90) are rare
antinuclear antibodies (ANA) reported in systemic sclerosis (SSc). Especially due to low …

Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research …

A Dima, MC Vonk, A Garaiman… - European journal of … - pubmed.ncbi.nlm.nih.gov
Background The anti-Nucleolar Organizer Region 90 antibodies (NOR90) are rare
antinuclear antibodies (ANA) reported in systemic sclerosis (SSc). Especially due to low …

Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research …

A Dima, M Vonk, A Garaiman, B Kersten… - EUROPEAN …, 2024 - iris.hunimed.eu
Background: The anti-Nucleolar Organizer Region 90 antibodies (NOR90) are rare
antinuclear antibodies (ANA) reported in systemic sclerosis (SSc). Especially due to low …

Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research …

A Dima, MC Vonk, A Garaiman, BE Kersten… - European Journal of … - ejinme.com
Abstract Background The anti-Nucleolar Organizer Region 90 antibodies (NOR90) are rare
antinuclear antibodies (ANA) reported in systemic sclerosis (SSc). Especially due to low …

Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research …

A Dima, MC Vonk, A Garaiman, BE Kersten… - European Journal of …, 2024 - Elsevier
Abstract Background The anti-Nucleolar Organizer Region 90 antibodies (NOR90) are rare
antinuclear antibodies (ANA) reported in systemic sclerosis (SSc). Especially due to low …